TickerFactsScreenerDevelopers

SUPERNUS PHARMACEUTICALS, INC. (SUPN) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2009: -$6.16M2010: -$44.32M2011: $9.44M2012: $57.57M2013: $33.46M2014: $40.70M2015: $88.01M2016: $191.75M2017: $267.48M2018: $453.02M2019: $595.43M2020: $744.86M2021: $815.85M2022: $886.20M2023: $921.52M2024: $1.04B2025: $1.06B$1.06B
2009Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$1.06B+2.5%
2024$1.04B+12.4%
2023$921.52M+4.0%
2022$886.20M+8.6%
2021$815.85M+9.5%
2020$744.86M+25.1%
2019$595.43M+31.4%
2018$453.02M+69.4%
2017$267.48M+39.5%
2016$191.75M+117.9%
2015$88.01M+116.2%
2014$40.70M+21.6%
2013$33.46M-41.9%
2012$57.57M+509.7%
2011$9.44M+121.3%
2010-$44.32M-619.9%
2009-$6.16M—